{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:28:47Z","timestamp":1775276927883,"version":"3.50.1"},"reference-count":53,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2463\/mrms.gl.2025-1000","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:09:28Z","timestamp":1743790168000},"page":"n\/a","source":"Crossref","is-referenced-by-count":4,"title":["Practical Brain MRI Guidelines for Anti-A\u03b2 Antibody Treatment in Early Symptomatic Alzheimer\u2019s Disease"],"prefix":"10.2463","volume":"24","author":[{"given":"Shingo","family":"Kakeda","sequence":"first","affiliation":[{"name":"Department of Radiology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohsuke","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harushi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Radiology, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya M.","family":"Tokumaru","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Neurophysiology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Working Group for Brain MRI Guidelines for Anti-A\u03b2 Antibody Treatment from The Japan Radiological Society, The Japanese Society for Neuroradiology, and The Japanese Society for Magnetic Resonance in Medicine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Iwatsubo T. Development of disease-modifying therapies against Alzheimer\u2019s disease. Psychiatry Clin Neurosci 2024; 78:491\u2013494.","DOI":"10.1111\/pcn.13681"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: New insights from new therapeutics. Nat Rev Drug Discov 2022; 21:306\u2013318.","DOI":"10.1038\/s41573-022-00391-w"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr., Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol 2021; 17:580\u2013589.","DOI":"10.1038\/s41582-021-00520-w"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 2023; 388:9\u201321.","DOI":"10.1056\/NEJMoa2212948"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Salloway S, Chalkias S, Barkhof F, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol 2022; 79:13\u201321.","DOI":"10.1001\/jamaneurol.2021.4161"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sperling R, Salloway S, Brooks DJ, et al. Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with Bapineuzumab: A retrospective analysis. Lancet Neurol 2012; 11:241\u2013249.","DOI":"10.1016\/S1474-4422(12)70015-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Carlson C, Siemers E, Hake A, et al. Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer\u2019s disease. Alzheimers Dement (Amst) 2016; 2:75\u201385.","DOI":"10.1016\/j.dadm.2016.02.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ketter N, Brashear HR, Bogert J, et al. Central review of amyloid-related imaging abnormalities in two Phase III clinical trials of Bapineuzumab in mild-to-moderate Alzheimer\u2019s disease patients. J Alzheimers Dis 2017; 57:557\u2013573.","DOI":"10.3233\/JAD-160216"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Barakos J, Purcell D, Suhy J, et al. Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with anti-amyloid beta therapy. J Prev Alzheimers Dis 2022; 9:211\u2013220.","DOI":"10.14283\/jpad.2022.21"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sperling RA, Jack CR Jr, Black SE, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement 2011; 7:367\u2013385.","DOI":"10.1016\/j.jalz.2011.05.2351"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Barakos J, Sperling R, Salloway S, et al. MR imaging features of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol 2013; 34:1958\u20131965.","DOI":"10.3174\/ajnr.A3500"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cogswell PM, Barakos JA, Barkhof F, et al. Amyloid-related imaging abnormalities with emerging Alzheimer disease therapeutics: Detection and reporting recommendations for clinical practice. AJNR Am J Neuroradiol 2022; 43:E19\u2013E35.","DOI":"10.3174\/ajnr.A7586"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kumamaru KK, Machitori A, Koba R, Ijichi S, Nakajima Y, Aoki S. Global and Japanese regional variations in radiologist potential workload for computed tomography and magnetic resonance imaging examinations. Jpn J Radiol 2018; 36:273\u2013281.","DOI":"10.1007\/s11604-018-0724-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): Radiological, biological and clinical characteristics. Brain 2023; 146:4414\u20134424.","DOI":"10.1093\/brain\/awad188"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease \u2014 one peptide, two pathways. Nat Rev Neurol 2020; 16:30\u201342.","DOI":"10.1038\/s41582-019-0281-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Filippi M, Cecchetti G, Spinelli EG, Vezzulli P, Falini A, Agosta F. Amyloid-related imaging abnormalities and \u03b2-amyloid-targeting antibodies: A systematic review. JAMA Neurol 2022; 79:291\u2013304.","DOI":"10.1001\/jamaneurol.2021.5205"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kakeda S, Korogi Y, Hiai Y, Ohnari N, Sato T, Hirai T. Pitfalls of 3D FLAIR brain imaging: A prospective comparison with 2D FLAIR. Acad Radiol 2012; 19:1225\u20131232.","DOI":"10.1016\/j.acra.2012.04.017"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tong KA, Ashwal S, Holshouser BA, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: Improved detection and initial results. Radiology 2003; 227:332\u2013339.","DOI":"10.1148\/radiol.2272020176"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Okuda T, Korogi Y, Shigematsu Y, et al. Brain lesions: When should fluid-attenuated inversion-recovery sequences be used in MR evaluation? Radiology 1999; 212:793\u2013798.","DOI":"10.1148\/radiology.212.3.r99se07793"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hayashida Y, Kakeda S, Hiai Y, et al. Diagnosis of intracranial hemorrhagic lesions: Comparison between 3D-SWAN (3D T2*-weighted imaging with multi-echo acquisition) and 2D-T2*-weighted imaging. Acta Radiol 2014; 55:201\u2013207.","DOI":"10.1177\/0284185113495836"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hiai Y, Kakeda S, Sato T, et al. 3D TOF MRA of intracranial aneurysms at 1.5 T and 3 T: Influence of matrix, parallel imaging, and acquisition time on image quality \u2014 a vascular phantom study. Acad Radiol 2008; 15:635\u2013640.","DOI":"10.1016\/j.acra.2007.12.021"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Goncalves Filho ALM, Awan KM, Conklin J, et al. Validation of a highly accelerated post-contrast wave-controlled aliasing in parallel imaging (CAIPI) 3D-T1 MPRage compared to standard 3D-T1 MPRage for detection of intracranial enhancing lesions on 3-T MRI. Eur Radiol 2023; 33:2905\u20132915.","DOI":"10.1007\/s00330-022-09265-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schultz V, Hedderich DM, Schmitz-Koep B, et al. Removing outliers from the normative database improves regional atrophy detection in single-subject voxel-based morphometry. Neuroradiology 2024; 66:507\u2013519.","DOI":"10.1007\/s00234-024-03304-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Inui S, Kaneda D, Sakurai K, Uchida Y, Abe O, Hashizume Y. Voxel-based morphometry of Alzheimer\u2019s disease using a localizer image: A comparative study with magnetization prepared rapid acquisition with gradient echo. Magn Reson Med Sci 2025; 24:103\u2013111.","DOI":"10.2463\/mrms.mp.2023-0093"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Goto M, Kamagata K, Andica C, et al. Deep learning-based hierarchical brain segmentation with preliminary analysis of the repeatability and reproducibility. Magn Reson Med Sci 2024:mp.2023-0124. [Epub ahead of print]","DOI":"10.2463\/mrms.mp.2023-0124"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Das SR, Ilesanmi A, Wolk DA, Gee JC. Beyond macrostructure: Is there a role for radiomics analysis in neuroimaging? Magn Reson Med Sci 2024; 23:367\u2013376.","DOI":"10.2463\/mrms.rev.2024-0053"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kim HG, Oh SW, Han D, Kim JY, Lim GY. Accelerated 3D T2-weighted images using compressed sensing for pediatric brain imaging. Neuroradiology 2022; 64:2399\u20132407.","DOI":"10.1007\/s00234-022-03028-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Iwamura M, Ide S, Sato K, et al. Thin-slice two-dimensional T2-weighted imaging with deep learning-based reconstruction: Improved lesion detection in the brain of patients with multiple sclerosis. Magn Reson Med Sci 2024; 23:184\u2013192.","DOI":"10.2463\/mrms.mp.2022-0112"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Estler A, Hauser TK, Mengel A, et al. Deep learning accelerated image reconstruction of fluid-attenuated inversion recovery sequence in brain imaging: Reduction of acquisition time and improvement of image quality. Acad Radiol 2024; 31: 180\u2013186.","DOI":"10.1016\/j.acra.2023.05.010"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Saito Y, Kamagata K, Andica C, et al. Reproducibility of automated calculation technique for diffusion tensor image analysis along the perivascular space. Jpn J Radiol 2023; 41: 947\u2013954.","DOI":"10.1007\/s11604-023-01415-0"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Saito Y, Kamagata K, Andica C, et al. Multisite harmonization of diffusion tensor image analysis along the perivascular space using the COMBined Association Test. Jpn J Radiol 2023; 41:1072\u20131083.","DOI":"10.1007\/s11604-023-01432-z"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lai YLL, Hsu FT, Yeh SY, et al. Atrophy of the cholinergic regions advances from early to late mild cognitive impairment. Neuroradiology 2024; 66:543\u2013556.","DOI":"10.1007\/s00234-024-03290-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wittens MMJ, Allemeersch GJ, Sima DM, et al. Towards validation in clinical routine: A comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer\u2019s disease diagnosis. Neuroradiology 2024; 66:487\u2013506.","DOI":"10.1007\/s00234-024-03280-8"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017; 89:88\u2013100.","DOI":"10.1212\/WNL.0000000000004058"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Sakurai K, Kaneda D, Morimoto S, et al. Medial temporal atrophy predicts the limbic comorbidities in lewy body disease. Neuroradiology 2025; 67:65\u201377.","DOI":"10.1007\/s00234-024-03502-z"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Lashley T, Rohrer JD, Mead S, Revesz T. Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol 2015; 41: 858\u2013881.","DOI":"10.1111\/nan.12250"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sakurai K, Tokumaru AM, Yoshida M, et al. Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: A retrospective analysis of the J-VAC study. Neuroradiology 2024; 66:1917\u20131929.","DOI":"10.1007\/s00234-024-03432-w"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Sachdev P, Kalaria R, O\u2019Brien J, et al. Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Dis Assoc Disord 2014; 28:206\u2013218.","DOI":"10.1097\/WAD.0000000000000034"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Quintas-Neves M, Almeida FC, Gauthreaux K, et al. Fazekas scale magnetic resonance imaging assessment in Alzheimer\u2019s disease and primary age-related tauopathy. Neuroradiology 2024; 66:2185\u20132193.","DOI":"10.1007\/s00234-024-03464-2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Graham NS, Sharp DJ. Understanding neurodegeneration after traumatic brain injury: From mechanisms to clinical trials in dementia. J Neurol Neurosurg Psychiatry 2019; 90:1221\u20131233.","DOI":"10.1136\/jnnp-2017-317557"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Graham NSN, Jolly A, Zimmerman K, et al. Diffuse axonal injury predicts neurodegeneration after moderate-severe traumatic brain injury. Brain 2020; 143:3685\u20133698.","DOI":"10.1093\/brain\/awaa316"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tullberg M, Toma AK, Yamada S, et al. Classification of chronic hydrocephalus in adults: A systematic review and analysis. World Neurosurg 2024; 183:113\u2013122.","DOI":"10.1016\/j.wneu.2023.12.094"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: A multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 2022; 21:714\u2013725.","DOI":"10.1016\/S1474-4422(22)00208-3"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Sakurai K, Tokumaru AM, Nakatsuka T, et al. Imaging spectrum of sporadic cerebral amyloid angiopathy: Multifaceted features of a single pathological condition. Insights Imaging 2014; 5:375\u2013385.","DOI":"10.1007\/s13244-014-0312-x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Sone J, Kitagawa N, Sugawara E, et al. Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry 2014; 85:354\u2013356.","DOI":"10.1136\/jnnp-2013-306084"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Stuckey SL, Goh TD, Heffernan T, Rowan D. Hyperintensity in the subarachnoid space on FLAIR MRI. AJR Am J Roentgenol 2007; 189:913\u2013921.","DOI":"10.2214\/AJR.07.2424"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: Clinical applications. AJR Am J Roentgenol 1992; 159:591\u2013599.","DOI":"10.2214\/ajr.159.3.1503032"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Roytman M, Mashriqi F, Al-Tawil K, et al. Amyloid-related imaging abnormalities: An update. AJR Am J Roentgenol 2023; 220:562\u2013574.","DOI":"10.2214\/AJR.22.28461"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Agarwal A, Gupta V, Brahmbhatt P, et al. Amyloid-related imaging abnormalities in Alzheimer disease treated with anti-amyloid-\u03b2 therapy. Radiographics 2023; 43:e230009.","DOI":"10.1148\/rg.230009"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Haller S, Haacke EM, Thurnher MM, Barkhof F. Susceptibility-weighted imaging: Technical essentials and clinical neurologic applications. Radiology 2021; 299:3\u201326.","DOI":"10.1148\/radiol.2021203071"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Tsushima Y, Endo K. Hypointensities in the brain on T2*-weighted gradient-echo magnetic resonance imaging. Curr Probl Diagn Radiol 2006; 35:140\u2013150.","DOI":"10.1067\/j.cpradiol.2006.04.002"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Weidauer S, Neuhaus E, Hattingen E. Cerebral superficial siderosis: Etiology, neuroradiological features and clinical findings. Clin Neuroradiol 2023; 33:293\u2013306.","DOI":"10.1007\/s00062-022-01231-5"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Kakeda S, Korogi Y, Ohnari N, et al. Superficial siderosis associated with a chronic subdural hematoma: T2-weighted MR imaging at 3T. Acad Radiol 2010; 17:871\u2013876.","DOI":"10.1016\/j.acra.2010.02.014"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/24\/4\/24_gl.2025-1000\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:30:31Z","timestamp":1763785831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/24\/4\/24_gl.2025-1000\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.gl.2025-1000","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"gl.2025-1000"}}